Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

285
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
285
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

46
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
46
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

94
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
94

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Physiologically-Based Pharmacokinetic Modeling to Investigate Piperaquine Exposure in Pregnant Women Using an Individualized Profile Approach.

Clinical and translational science·2026
Same author

Dengue virus non-structural protein 1 as a surrogate biomarker of antiviral efficacy in early phase clinical trials.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same author

Population pharmacokinetics of DNDI-6148 in healthy adults.

PLoS neglected tropical diseases·2026
Same author

Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African Adults.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modelling.

British journal of clinical pharmacology·2026

Related Experiment Video

Updated: Jun 8, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.0K

Pharmacometric and statistical considerations for dose optimization.

Palang Chotsiri1, Prasert Yodsawat1, Richard M Hoglund1,2

  • 1Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

CPT: Pharmacometrics & Systems Pharmacology
|November 6, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a new pharmacometric method for drug dose optimization when target concentrations are unknown, particularly for pediatric populations. The approach ensures equivalent pharmacokinetic and pharmacodynamic outcomes to typical patient groups, aiding in effective treatment strategies.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.5K

Related Experiment Videos

Last Updated: Jun 8, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.0K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.5K

Area of Science:

  • Pharmacometrics
  • Drug Development
  • Pediatric Pharmacology

Background:

  • Probability of Target Attainment (PTA) is crucial for drug dose optimization but requires known target concentrations.
  • Target thresholds are often unavailable for specific patient groups, especially children.
  • Existing methods lack flexibility for unknown pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PKPD) targets.

Purpose of the Study:

  • To explore statistical approaches for determining optimal drug doses when PK and PKPD targets are unknown.
  • To develop a robust and reproducible pharmacometric method for dose optimization in diverse populations.
  • To create a freely accessible tool for practical application in clinical settings.

Main Methods:

  • Performed pharmacokinetic and PKPD simulations using standard adult dosing as a reference profile.
  • Compared simulated outcomes across various dosing regimens in the target population.
  • Calculated statistical distances between empirical cumulative distribution functions of outcomes.
  • Selected optimal doses to match reference PK/PKPD profiles for unknown targets.

Main Results:

  • Developed a novel pharmacometric method for dose optimization with known and unknown targets.
  • Demonstrated robustness and reproducibility of the developed methods.
  • Implemented all methods in an open-source, freely available Shiny web application.

Conclusions:

  • The new pharmacometric method effectively optimizes drug dosage in populations with unknown PK/PKPD targets.
  • The accessible Shiny web application facilitates widespread adoption and use in dose optimization.
  • This approach provides a valuable tool for tailoring drug regimens, particularly for pediatric patients.